Benign prostatic hyperplasia: Difference between revisions

Jump to navigation Jump to search
Charmaine Patel (talk | contribs)
No edit summary
WikiBot (talk | contribs)
m Bot: Removing from Primary care
 
(14 intermediate revisions by 4 users not shown)
Line 1: Line 1:
'''For patient information page, click [[{{PAGENAME}} (patient name)|here]]
__NOTOC__
'''For patient information, click [[{{PAGENAME}} (patient information)|here]]


{{Infobox_Disease |
  Name          = {{PAGENAME}} |
  Image          = |
  Caption        = |
  DiseasesDB    = 10797 |
  ICD10          = {{ICD10|N|40||n|40}} |
  ICD9          = {{ICD9|600}} |
  ICDO          = |
  OMIM          = |
  MedlinePlus    = |
  MeshID        = D011470 |
}}
{{Benign prostatic hyperplasia}}
{{Benign prostatic hyperplasia}}
{{SCC}}
{{SCC}}


{{SK}} Hyperplasia of the Postate; Prostate hyperplasia, benign; prostatic hypertrophy; adenofibromatous hypertrophy of prostate; benign prostatic hypertrophy


==[[Benign prostatic hyperplasia overview|Overview]]==


==Treatment==
==[[Benign prostatic hyperplasia historical perspective|Historical Perspective]]==
 
==[[Benign prostatic hyperplasia pathophysiology|Pathophysiology]]==
 
==[[Benign prostatic hyperplasia causes|Causes]]==
 
==[[Benign prostatic hyperplasia differential diagnosis|Differentiating Benign Prostatic Hyperplasia from other Diseases]]==
 
==[[Benign prostatic hyperplasia epidemiology and demographics|Epidemiology and Demographics]]==
 
==[[Benign prostatic hyperplasia risk factors|Risk Factors]]==
 
==[[Benign prostatic hyperplasia screening|Screening]]==  


==[[Benign prostatic hyperplasia natural history, complications and prognosis|Natural History, Complications and Prognosis]]==


==Diagnosis==


===Surgery===
[[Benign prostatic hyperplasia history and symptoms|History and Symptoms]] | [[Benign prostatic hyperplasia physical examination|Physical Examination]] | [[Benign prostatic hyperplasia laboratory findings|Laboratory Findings]] | [[Benign prostatic hyperplasia ultrasound|Ultrasound]] | [[Benign prostatic hyperplasia other imaging findings|Other Imaging Findings]] | [[Benign prostatic hyperplasia other diagnostic studies|Other Diagnostic Studies]]
If medical treatment fails, [[transurethral resection of prostate]] (TURP) surgery may need to be performed. This involves removing (part of) the prostate through the [[urethra]].  There are also a number of new methods for reducing the size of an enlarged prostate, some of which have not been around long enough to fully establish their safety or side effects.  These include various methods to destroy or remove part of the excess tissue while trying to avoid damaging what's left.  Transurethral electrovaporization of the prostate (TVP), laser TURP, visual laser ablation (VLAP), TransUrethral Microwave ThermoTherapy (TUMT), [[Transurethral needle ablation of the prostate|TransUrethral Needle Ablation]] (TUNA), ethanol injection, and others are studied as alternatives.


Newer techniques involving lasers in urology have emerged in the last 5-10 years.  Starting with the VLAP technique involving the [[Nd:YAG laser]] with contact on the prostatic tissue.  A similar technology called Photoselective Vaporization of the Prostate (PVP) with the GreenLight (KTP) laser have emerged very recently.  This procedure involves a high powered 80 Watt KTP laser with a 550 micrometre laser fiber inserted into the prostate.  This fiber has an internal reflection with a 70 degree deflecting angle.  It is used to vaporize the tissue to the prostatic capsule.  KTP lasers target haemoglobin as the chromophore and have typically have a penetration depth of 2.0mm (four times deeper than holmium).
==Treatment==


Another procedure termed Holmium Laser Ablation of the Prostate (HoLAP) has also been gaining acceptance around the world.  Like KTP the delivery device for HoLAP procedures is a 550um disposable side-firing fiber that directs the beam from a high powered 100 Watt laser at a 70degree from the fiber axis.  The holmium wavelength is 2,140nm, which falls within the infrared portion of the spectrum and is invisible to the naked eye.  Where KTP relies on haemoglobin as a chromophore, water within the target tissue is the chromophore for Holmium lasers.  The pentration depth of Holmium lasers is <0.5mm avoiding complications associated with tissue necrosis often found with the deeper penetration and lower peak powers of KTP.
[[Benign prostatic hyperplasia medical therapy|Medical Therapy]] | [[Benign prostatic hyperplasia surgery|Surgery]] | [[Benign prostatic hyperplasia primary prevention|Primary Prevention]] | [[Benign prostatic hyperplasia secondary prevention|Secondary Prevention]] | [[Benign prostatic hyperplasia cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Benign prostatic hyperplasia future or investigational therapies|Future or Investigational Therapies]]


Both wavelengths, KTP and Holmium, ablate approximately one to two grams of tissue per minute.
==Case Studies==
[[Benign prostatic hyperplasia case study one|Case #1]]


==Related chapters==
==Related chapters==
Line 39: Line 44:
*[[Uvula of urinary bladder]]
*[[Uvula of urinary bladder]]


==References==
 
{{Reflist|2}}


{{Urologicals}}
{{Urologicals}}
{{Diseases of the pelvis, genitals and breasts}}
{{Diseases of the pelvis, genitals and breasts}}
{{Geriatrics}}
{{Geriatrics}}
[[Category:Andrology]]
[[Category:Urology]]
[[de:Benigne Prostatahyperplasie]]
[[de:Benigne Prostatahyperplasie]]
[[es:Hipertrofia benigna de próstata]]
[[es:Hipertrofia benigna de próstata]]
Line 66: Line 65:
{{WikiDoc Help Menu}}
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}
{{WikiDoc Sources}}
[[Category:Andrology]]
[[Category:Urology]]
[[Category:Surgery]]
[[Category:Disease]]

Latest revision as of 20:36, 29 July 2020

For patient information, click here

Benign prostatic hyperplasia Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Benign Prostatic Hyperplasia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Benign prostatic hyperplasia On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Benign prostatic hyperplasia

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Benign prostatic hyperplasia

CDC on Benign prostatic hyperplasia

Benign prostatic hyperplasia in the news

Blogs on Benign prostatic hyperplasia

Directions to Hospitals Treating Benign prostatic hyperplasia

Risk calculators and risk factors for Benign prostatic hyperplasia

Steven C. Campbell, M.D., Ph.D.

Synonyms and keywords: Hyperplasia of the Postate; Prostate hyperplasia, benign; prostatic hypertrophy; adenofibromatous hypertrophy of prostate; benign prostatic hypertrophy

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Benign Prostatic Hyperplasia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms | Physical Examination | Laboratory Findings | Ultrasound | Other Imaging Findings | Other Diagnostic Studies

Treatment

Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies

Case Studies

Case #1

Related chapters


Template:Diseases of the pelvis, genitals and breasts

de:Benigne Prostatahyperplasie it:Ipertrofia prostatica benigna ka:პროსტატის კეთილთვისებიანი ჰიპერპლაზია nl:Benigne prostaathypertrofie fi:Eturauhasen liikakasvu


Template:WikiDoc Sources